R Accelerated Award Grants
Forecasted
Alex's Lemonade Stand Foundation’s R Accelerated Award Grants support innovative research advancing safer, more effective therapies for childhood cancers.
Funder: Alex's Lemonade Stand Foundation
Due Dates (Anticipated): June 2027 (Full application, projected)
Funding Amounts: $800,000 total over 4 years per award; no indirect costs allowed.
Summary: Supports original, hypothesis-driven pediatric oncology research accelerating discovery of more effective, less toxic childhood cancer therapies.
Key Information: Forecasted opportunity; eligibility limited to first-time PIs/co-PIs of pediatric cancer–focused NIH R01 or equivalent awards within last 5 years.
Description
This opportunity from Alex's Lemonade Stand Foundation (ALSF) provides substantial support for established investigators aiming to advance innovative, hypothesis-driven research in pediatric oncology. The program specifically targets projects that accelerate the development of more effective and less toxic therapies for childhood cancers, building upon significant prior achievements such as a recent NIH R01 or equivalent award. The grant encourages high-impact research that aligns with ALSF’s mission to find cures and better treatments for childhood cancers.
